U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)) - Forecasts to 2021

Publisher Name :
Date: 25-Jan-2017
No. of pages: 144
Inquire Before Buying

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021.

In 2016, the cognitive behavioral therapy for insomnia (CBTI) segment is expected to account for the largest share of the market. The other alternative therapies include exercise/yoga, acupuncture, biofeedback, bright light therapy, music therapy, and aroma therapy.

In 2016, the prescription sleep aids segment is expected to account for the largest share of the U.S. insomnia pharmacological treatment market. The launch of Belsomra(Merck & Co., Inc) in 2014 in the U.S. and the anticipated launch of E-2006 (Eisai Co., Ltd.) is expected to drive the growth of the market during the forecast years. However, due to the erosion in branded drugs sales and growing adoption of generics attributed to their low cost and equal efficacy as compared to branded products may hinder the growth of the market. In 2016, the zolpidem segment is expected to account for the largest share of the non-benzodaizepines prescription sleep aids market. However, higher adoption of generic products that are available are cheaper price is negatively affecting the growth of the market.

The over-the-counter sleep aids segment of the U.S. insomnia pharmacological treatment market is expected to grow at the highest CAGR during the forecast period. Reasons attributing to the growth of this market include easier availability, low prices, and publicity regarding the side effects of the prescription sleep aids has also steered the patients towards OTC sleep aid. In 2016, the antihistamines sleep aids segment is expected to hold the largest share of the over-the-counter sleep aids market, whereas, melatonin is expected to grow at the highest CAGR during the forecast period. Growing awareness about the advantages of melatonin such as least amount of side effects, reduces stress levels, and its growing consumption is driving the growth of this segment in the U.S.

Some of the key players offering insomnia treatment (pharmacological)include Eisai, Co. Ltd. (Japan), Merck & Co., Inc. (U.S.), Meda Consumer Healthcare Inc. (U.S.), Pfizer, Inc. (U.S.), Sanofi (France), Takeda Pharmaceutical Company Ltd. (Japan), Pernix Therapeutics (U.S.), and Purdue Pharma L.P. (U.S.).

Research Coverage

The market study covers the U.S. insomnia market, by type of treatment, to estimate the overall market size during 2013 to 2021.This report also covers the drivers, restraints, and opportunities of the market along with the competitive landscape of the U.S. insomnia market players.

Reasons to buy this report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:


  • Market Penetration: Comprehensive information regarding products and services offered by the top players in the U.S. insomnia market

  • Product Development/Innovation: Detailed insights on research & development activities, and new product launches in the U.S. insomnia market

  • Market Diversification: Exhaustive information about new products, recent developments, and investments in the U.S. insomnia market

  • Competitive Assessment: In-depth assessment of strategies, products, and pipeline products of the key players in the U.S. insomnia market

U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)) - Forecasts to 2021

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Key Stakeholders/Influencers

2 Research Methodology
2.1 Market Size Estimation – Non-Pharmacological Treatments Market
2.1.1 Market Breakdown and Data Triangulation
2.1.2 Key Data From Secondary Sources
2.1.3 Key Data From Primary Sources
2.2 Market Size Estimation – Pharmacological Treatments Market
2.2.1 Market Forecast Model
2.2.2 Market Size Estimation
2.2.3 Market Breakdown and Data Triangulation
2.2.4 Key Data From Primary and Secondary Sources
2.3 Research Assumptions

3 Executive Summary

4 Premium Insights
4.1 Physicians Views About Cognitive Behavioral Therapy for Insomnia (CBTI)
4.2 Age-Wise Commonly Used/Prescribed Treatments for Each Type of Insomnia
4.3 List of Ongoing Phase-III Clinical Trails for Insomnia
4.4 U.S. Insomnia Market: Consumer Selection Criteria

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Government Support to Control Rising Insomnia Cost
5.2.1.2 OTC Sleep Aids to Drive the Pharmacological Treatment Market Growth
5.2.2 Market Restraints
5.2.2.1 Erosion in Branded Prescription Sleep Aid Sales Due to Growing Adoption of Generics
5.2.2.2 Side Effects of Benzodiazepine and Non-Benzodiazepine Drugs
5.2.2.3 Non Pharmacological Therapies to Restrict the Growth of Drugs Market
5.2.3 Market Opportunities
5.2.3.1 Unmet Need for More Effective and Safe Drugs
5.2.3.2 Presence of Large Insomnia Population Pool

6 Non-Pharmacological Treatment Market
6.1 Introduction
6.1.1 Cognitive Behavioral Therapy for Insomnia (CBTI)
6.1.2 Hypnotherapy
6.1.3 Other Alternative Therapies
6.2 Therapy Recommendation, 2015 (%)
6.3 Qualitative Assessment

7 Pharmacological Treatment Market
7.1 Introduction
7.2 U.S.: Insomnia Pharmacological Treatment Market Size, By Type
7.2.1 U.S.: Prescription Sleep Aids Market Size for Insomnia
7.2.1.1 U.S.: Prescription Sleep Aids Market Size for Insomnia, By Type
7.2.1.1.1 U.S.: Non- Benzodiazepine Sleep Aids Market Size for Insomnia, By Type
7.2.2 U.S.: Over-The-Counter (OTC) Sleep Aids Market Size for Insomnia, By Type

8 Competitive Landscape
8.1 Key Players in the U.S. Insomnia Pharmacological Treatment Market
8.2 Top Available Mobile Applications for Insomnia
8.3 Corporate Strategies Followed Within U.S. Insomnia Market
8.4 Competitive Situations & Trends
8.4.1 Product Launches & Approvals
8.4.2 Collaborations, Agreements and Partnerships
8.4.3 Acquisitions

9 Company Profiles
9.1 Introduction
9.2 Merck & Co., Inc.
9.3 Eisai Co., Ltd.
9.4 Meda Consumer Healthcare, Inc
9.5 Takeda Pharmaceuticals Company Ltd.
9.6 Pfizer Inc.
9.7 Sanofi
9.8 Vanda Pharmaceuticals
9.9 Pernix Therapeutics
9.10 Purdue Pharmaceuticals L.P.

10 Appendix
10.1 Discussion Guide
10.2 Related Reports
10.3 Related Reports
10.4 Knowledgestore Subscription Portal
10.5 MnM Knowledgestore: Snapshot
10.6 RT: Real-Time Market Intelligence
10.7 Disclaimer
10.8 Author Details

List of Tables

Table 1 Key Stakeholders/Influencers for Diagnosed Insomnia Patients
Table 2 Physicians Views About Cognitive Behavioral Therapy for Insomnia (CBTI)
Table 3 Age-Wise Commonly Used/Prescribed Treatments for Each Type of Insomnia
Table 4 List of Ongoing Phase-III Clinical Trails for Insomnia
Table 5 Insomnia Treatment Selection Criteria: Impact Analysis
Table 6 U.S. Insomnia Market, By Non-Pharmacological Treatment (Qualitative Assessment)
Table 7 U.S.: Insomnia Pharmacological Treatment Market Size , By Type, 2013-2021 (USD Million)
Table 8 U.S.: Insomnia Pharmacological Treatment Market Size , By Prescription Sleep Aids, 2013-2021 (USD Million)
Table 9 U.S.: Prescriptions Sleep Aids Market Size for Insomnia, By Type, 2013-2021 (USD Million)
Table 10 U.S.: Non- Benzodiazepine Sleep Aids Market Size for Insomnia, By Type, 2013-2021 (USD Million)
Table 11 U.S.: Over-The-Counter (OTC) Sleep Aids Market Size for Insomnia, By Type, 2013-2021 (USD Million)
Table 12 Key Players in the U.S. Insomnia Pharmacological Treatment Market (2016)
Table 13 Top Available Mobile Applications for Insomnia (2016)
Table 14 Product Launches and Approvals, 2013 –2016
Table 15 Collaborations, Agreements and Partnerships 2013–2016
Table 16 Acquisitions, 2013–2016

List of Figures

Figure 1 Segmentation & Coverage
Figure 2 Prevalence of Insomnia, By Type (2012-2015)
Figure 3 Research Design – Non-Pharmacological Treatments Market
Figure 4 Market Breakdown and Data Triangulation – Non-Pharmacological Treatments Market
Figure 5 Forecasting Model– Pharmacological Treatments Market
Figure 6 Market Size Estimation – Pharmacological Treatments Market
Figure 7 Market Breakdown and Data Triangulation – Pharmacological Treatments Market
Figure 8 Assumptions for the Study
Figure 9 U.S. Insomnia Market Scope
Figure 10 Pharmacological Treatment Market Share, By Type (2014-2021)
Figure 11 U.S. Insomnia Market: Consumer Selection Criteria
Figure 12 U.S. Insomnia Market: Drivers, Restraints, and Opportunities
Figure 13 U.S. Insomnia Market, By Non-Pharmacological Treatment, Therapy Recommendation, 2015 (%)
Figure 14 U.S. Insomnia Pharmacological Treatment Market Segmentation
Figure 15 U.S.: Insomnia Pharmacological Treatment Market, 2013-2021 (USD Million)
Figure 16 Market Share: Pharmacological Treatment Market (2016)
Figure 17 Market Share: Prescription Sleep Aids Market (2016)
Figure 18 U.S. Insomnia Prescription Sleep Aids Market Snapshot
Figure 19 Market Share: Non-Benzodiazepine Sleep Aids Market (2016)
Figure 20 Market Share: Non-Benzodiazepine Sleep Aids Market (2016)
Figure 21 U.S.: Over-The-Counter (OTC) Sleep Aids Market Snapshot
Figure 22 Battle for Market Share: Product Launches and Approvals—Key Strategies Adopted By Market Players (2013-2016)
Figure 23 Geographic Revenue Mix of Major Players in the U.S. Insomnia Market (2016)
Figure 24 Sumitomo Dainippon Pharma Co., Ltd.: Company Snapshot (2015)
Figure 25 Sanofi: Company Snapshot (2015)
Figure 26 Pfizer Inc: Company Snapshot (2015)
Figure 27 Takeda Pharmaceutical Company Ltd.: Company Snapshot (2015)
Figure 28 Merck & Co., Inc.: Company Snapshot (2015)
Figure 29 Meda Consumer Healthcare Inc.: Company Snapshot (2015)
Figure 30 Eisai Co., Ltd.: Company Snapshot (2015)
Figure 31 Purdue Pharmaceuticals L.P.: Company Snapshot (2015)
Figure 32 Pernix Therapeutics: Company Snapshot (2015)
Figure 33 Vanda Pharmaceuticals: Company Snapshot (2015)

  • Global Auto-Injectors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 136
    Auto-injector is a medical device designed to deliver a dose of a particular drug. Most auto-injectors are spring-loaded syringes. By design, auto-injectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The site of injection depends on the drug loaded, but it typically is administered into the thigh or the buttocks. Scope of the Report: This report focuses on the Auto-Injectors in global market, especi......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Auto-Injectors Market 2018, Forecast to 2023
    Published: 17-Aug-2018        Price: US 4880 Onwards        Pages: 132
    Auto-injector is a medical device designed to deliver a dose of a particular drug. Most auto-injectors are spring-loaded syringes. By design, auto-injectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The site of injection depends on the drug loaded, but it typically is administered into the thigh or the buttocks. Scope of the Report: This report focuses on the Auto-Injectors in global market, especi......
  • Global Closed System Drug Transfer Device (CSTD) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 130
    Closed System Drug Transfer Device (CSTD) is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration. Scope of the Report: This report focuses on the Closed System Drug Transfer Device (CSTD) in global market, especially......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Closed System Drug Transfer Device (CSTD) Market 2018, Forecast to 2023
    Published: 17-Aug-2018        Price: US 4880 Onwards        Pages: 135
    Closed System Drug Transfer Device (CSTD) is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration. Scope of the Report: This report focuses on the Closed System Drug Transfer Device (CSTD) in global market, especially......
  • Global Contrast Media (Contrast Agents) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 133
    Contrast media (or contrast agents) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure. Contrast agents are commonly used to improve the visibility of blood vessels and the gastrointestinal tract. Several ty......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Contrast Media (Contrast Agents) Market 2018, Forecast to 2023
    Published: 17-Aug-2018        Price: US 4880 Onwards        Pages: 137
    Contrast media (or contrast agents) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure. Contrast agents are commonly used to improve the visibility of blood vessels and the gastrointestinal tract. Several ty......
  • Global Viral Vectors and Plasmid DNA Manufacturing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 150
    The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases. Scope of the Report: This report studies the Viral Vectors and Plasmid DNA Manufacturing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Viral Vectors and Plasmid DNA Manufacturing market by product typ......
  • 2018-2023 Global Medical Guide Wire Consumption Market Report
    Published: 16-Aug-2018        Price: US 4660 Onwards        Pages: 162
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Medical Guide Wire market for 2018-2023. A guidewire is a long and flexible spring that assists the introduction and placement of implantable medical devices into a patient's body. Global giant manufactures mainly distributed in Japan and USA. The manufacturers in Japan have a long history and unshakable status in this field. Manufacturers such as Te......
  • Global Disposable Medical Devices Sensors Market Professional Survey Report 2018
    Published: 16-Aug-2018        Price: US 3500 Onwards        Pages: 119
    This report studies the global Disposable Medical Devices Sensors market status and forecast, categorizes the global Disposable Medical Devices Sensors market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Disposable medical devices sensors are handheld or portable scanning devices ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs